SNOA

Sonoma Pharmaceu

• Seeking Alpha·08/06 13:07

  Sonoma Pharmaceuticals GAAP EPS of -$0.09, revenue of $6.41M

• TipRanks·06/30 13:05

  Sonoma Pharmaceuticals receives 510(k) clearance for Microdacyn solution

• NASDAQ·06/26 16:04

  Jade Biosciences Appoints Mark Eisner To The Board Of Directors

• TipRanks·06/18 22:41

  Sonoma Pharmaceuticals Expands At-the-Market Equity Offering Capacity

• Seeking Alpha·06/16 20:24

  Sonoma Pharmaceuticals GAAP EPS of -$0.33, revenue of $5.56M

• TipRanks·04/30 22:55

  Sonoma Pharmaceuticals Completes Equity Offering to Raise Capital

• NASDAQ·04/27 10:02

  Sonoma Pharma Prices $4 Mln Offering Of Shares And Warrants

• TipRanks·04/24 13:32

  Sonoma Pharmaceuticals prices 2.96M shares at $1.35 in public offering

• Dow Jones·04/17 22:10

  *Sonoma Pharmaceuticals Files to Offer Units Consisting of Stock and Warrants

• TipRanks·04/17 21:31

  Sonoma Pharmaceuticals files to sell units, no amount given

• TipRanks·04/09 13:34

  Sonoma Pharmaceuticals Signs U.S. Microcyn Supply Agreement

• TipRanks·03/24 12:45

  Sonoma announces U.S. retail launch of advanced burn relief hydrogel

• TipRanks·03/18 13:00

  Sonoma Pharmaceuticals launches Aquanil AD

• Seeking Alpha·02/10 21:44

  Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $4.3M

• TipRanks·01/12 14:11

  Sonoma Pharmaceuticals Updates Investor Presentation on HOCl Portfolio